A second Phase 3 Pivotal study of mdHACM injection in the treatment of Knee Osteoarthritis
Latest Information Update: 22 Jun 2022
At a glance
- Drugs DHACM (Primary)
- Indications Osteoarthritis
- Focus Registrational; Therapeutic Use
- Sponsors MiMedx
Most Recent Events
- 15 Jun 2022 According to a MiMedx media release, MIMEDX engages Nordic Bioscience Clinical Development A/S to propel registrational trials of placental biologic injectable for Knee Osteoarthritis
- 15 Jun 2022 According to a MiMedx media release, the company expects to initiate this trial later this year.
- 13 Jan 2022 New trial record